胰岛自身免疫启动及进展为多自身抗体和临床糖尿病的预测因素:TEDDY研究
TEDDY研究对8502名遗传高危新生儿随访中位11.2年,835名(9.8%)出现胰岛自身抗体,283名(3.3%)诊断为1型糖尿病。以胰岛素自身抗体为首发(IAA-first)与以GAD自身抗体为首发(GADA-first)的血清转换预测因素不同,且与进展至糖尿病的预测因素不同。年轻血清转换年龄预测从单一进展为多自身抗体及进展至糖尿病,但GADA-first者除外。
要点
- 男性、芬兰居住、兄弟姐妹患1型糖尿病、HLA DR4等位基因、28天前使用益生菌及SNP rs689_A(INS)预测IAA-first血清转换。
- 12个月体重增加及SNP rs12708716_G(CLEC16A)和rs2292239_T(ERBB3)预测GADA-first。
- 年轻血清转换年龄预测从单一进展为多自身抗体及进展至糖尿病,但GADA-first者除外。
核心结论
- IAA-first与GADA-first自身免疫的预测因素彼此不同,且与进展至糖尿病的预测因素不同。
研究设计与样本
- 遗传高危新生儿(n=8502)随访中位11.2年(四分位距9.3-12.6年)。
- 835名(9.8%)出现胰岛自身抗体,283名(3.3%)诊断为1型糖尿病。
- 使用Cox比例风险模型分析预测因素。
主要发现
- 男性、芬兰居住、兄弟姐妹患1型糖尿病、HLA DR4等位基因、28天前使用益生菌及SNP rs689_A(INS)预测IAA-first血清转换。
- 12个月体重增加及SNP rs12708716_G(CLEC16A)和rs2292239_T(ERBB3)预测GADA-first。
- 父亲患1型糖尿病者,SNP rs2476601_A(PTPN22)和rs3184504_T(SH2B3)预测两者。
- 年轻血清转换年龄预测从单一进展为多自身抗体及进展至糖尿病,但GADA-first者除外。
- 1型糖尿病家族史和HLA DR4等位基因预测进展为多自身抗体但不预测糖尿病;性别不预测进展为多自身抗体,但男性从多自身抗体进展至糖尿病较女性慢;SKAP2和MIR3681HG SNP新报道与多自身抗体进展至1型糖尿病显著相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies and from multiple autoantibodies to type 1 diabetes in young children. RESEARCH DESIGN AND METHODS: Genetically high-risk newborns (n = 8,502) were followed for a median of 11.2 years (interquartile range 9.3-12.6); 835 (9.8%) developed islet autoantibodies and 283 (3.3%) were diagnosed with type 1 diabetes. Predictors were examined using Cox proportional hazards models. RESULTS: Predictors of seroconversion and progression differed, depending on the type of first appearing autoantibody. Male sex, Finnish residence, having a sibling with type 1 diabetes, the HLA DR4 allele, probiotic use before age 28 days, and single nucleotide polymorphism (SNP) rs689_A (INS) predicted seroconversion to IAA-first (having islet autoantibody to insulin as the first appearing autoantibody). Increased weight at 12 months and SNPs rs12708716_G (CLEC16A) and rs2292239_T (ERBB3) predicted GADA-first (autoantibody to GAD as the first appearing). For those having a father with type 1 diabetes, the SNPs rs2476601_A (PTPN22) and rs3184504_T (SH2B3) predicted both. Younger age at seroconversion predicted progression from single to multiple autoantibodies as well as progression to diabetes, except for those presenting with GADA-first. Family history of type 1 diabetes and the HLA DR4 allele predicted progression to multiple autoantibodies but not diabetes. Sex did not predict progression to multiple autoantibodies, but males progressed more slowly than females from multiple autoantibodies to diabetes. SKAP2 and MIR3681HG SNPs are newly reported to be significantly associated with progression from multiple autoantibodies to type 1 diabetes. CONCLUSIONS: Predictors of IAA-first versus GADA-first autoimmunity differ from each other and from the predictors of progression to diabetes.
引用
- Krischer JP, Liu X, Lernmark Å, et al. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study. Diabetes Care. 2022. PMID: 36150053. doi:10.2337/dc21-2612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。